IRON
IRON
NASDAQ · Biotechnology

Disc Medicine Inc

$59.11
+0.94 (+1.62%)
Financial Highlights (FY 2025)
Revenue
1.46B
Net Income
-261,677,643
Gross Margin
66.6%
Profit Margin
-18.0%
Rev Growth
+12.9%
D/E Ratio
0.11
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 66.6% 66.6% 66.6%
Operating Margin -26.5% -24.4% -22.1%
Profit Margin -18.0% -20.2% -21.1%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 1.46B 1.47B 1.18B
Gross Profit 970.17M 981.04M 788.89M
Operating Income -386,837,737 -359,859,999 -261,599,197
Net Income -261,677,643 -297,076,371 -250,070,353
Gross Margin 66.6% 66.6% 66.6%
Operating Margin -26.5% -24.4% -22.1%
Profit Margin -18.0% -20.2% -21.1%
Rev Growth +12.9% +6.2% -8.5%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 219.62M 263.84M 276.64M
Total Equity 2.04B 2.26B 2.20B
D/E Ratio 0.11 0.12 0.13
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -537,620,569 -578,764,523 -403,482,661
Free Cash Flow -321,004,356 -279,609,663 -183,137,834